This is due to estrogen’s effect on proliferation and invasion of gastric cancer, which could be prevented by administration of tamoxifen, an estrogen receptor antagonist.[21] A high BMI was also a risk factor for lymph node metastasis in our study. The gene discussed is ESR1; the disease is metastatic malignant neoplasm in the lymph nodes.